Suppliers Cellecta, Inc.
Cellecta provides contract research services for the discovery and characterization of novel drug targets, and the development of novel therapeutics.
Cellecta’s genome-wide and targeted RNAi screening platform, which combines complex lentiviral shRNA expression libraries with HT sequencing, enables identification of genes regulating a variety of cellular responses and possible therapeutic targets and helps researchers identify new targets, prioritize known targets, characterize therapeutic mechanisms of action, and identify genes that induce an additive or synergistic response.
The approach is particularly useful in elucidating the mechanism of action for compounds and for investigators interested in identifying essential genes in cancer models.
Cellecta provides complete lentiviral vector cloning services for construction of shRNA controls, reporters, and expression plasmids. As a result of our...
Using pooled lentiviral-based shRNA libraries, Cellecta has developed an effective, scalable, high-throughput platform for broad range screening and...
Cellecta has the expertise and capability to generate high quality complex heterogeneous libraries consisting of virtually any defined sequences. This...
To provide genome-wide coverage of the entire annotated human and mouse gene sets, we have developed the DECIPHER shRNA Libraries. These are sets of pooled...
Get the Best Promotions
.gif?1376593640 "Biosave Filter")
